Actively Recruiting
Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy
Led by West China Second University Hospital · Updated on 2024-07-31
70
Participants Needed
1
Research Sites
3 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying intermittent catheterization in patients who have undergone radical cervical cancer surgery. The study aims to summarize the best existing evidence, develop a nursing protocol for intermittent catheterization based on this evidence combined with clinical practice, and evaluate how well this protocol works in real clinical settings. This research will help improve standardized care and guidelines for patients after this surgery in China. The study compares two approaches: a best evidence-based intermittent catheterization protocol and routine intermittent catheterization care. Participants will be randomly assigned to one of these groups. The trial uses a triple-blind design to ensure unbiased results. The main treatment phase focuses on applying these catheterization protocols after surgery. Participants will be monitored for urinary complications within two months after discharge. Researchers will also assess catheterization compliance, quality of life using a 12-item survey, anxiety levels, and confidence with catheterization before the intervention, immediately after, and one month post-discharge. Health service use will also be tracked during the two months following discharge. This allows a thorough evaluation of the nursing protocol's clinical effects and patient outcomes.
CONDITIONS
Brief Title
Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Underwent radical cervical cancer surgery and intermittent catheterization at the hospital conducting the study
- Participant or family members can operate a smartphone
- No cognitive or psychiatric disorders and able to communicate effectively
You will not qualify if you...
- Serious heart, brain, lung, or other major organ diseases
- Water, electrolyte, or acid-base balance disorders at the start of intermittent catheterization
- Previous serious kidney diseases or bladder and urethra surgery
- Urinary tract infections
- Did not complete all interventions or data collection
- Voluntarily withdrew from the study or died during the study period
- Refused to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 months post-discharge
Participants follow an intermittent catheterization protocol based on the best evidence or routine intermittent catheterization care after radical cervical cancer surgery.
Assessments before intervention, immediately after intervention, and 1 month post-discharge
Trial Site Locations
Total: 1 location
1
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
Actively Recruiting
Research Team
L
Lu Xing
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here